F1000Research (May 2022)

Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome and a pulmonary sarcoidosis [version 2; peer review: 2 approved]

  • Laura Courtellemont,
  • Abdelkrim El Khalil,
  • Laurent Bret,
  • Clémence Guillaume,
  • Olivier Perche,
  • Khalid Khadre,
  • Thomas Guery,
  • Sophie Iquel,
  • Thomas Francia,
  • Julie Bois,
  • Thomas Brungs,
  • Julien Decker,
  • Laurence Got,
  • Sylvain Briault,
  • Toufik Kamel,
  • Benoit Delamare,
  • Jérôme Guinard,
  • Thierry Boulain,
  • Eric Legac,
  • Lekbir Baala,
  • Dalila Benzekri-Lefevre

Journal volume & issue
Vol. 9

Abstract

Read online

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and has been a global public health concern. We report coinfection of SARS-CoV-2 and 2009 H1N1 Influenza strain in a French patient with pneumonia leading to acute respiratory distress syndrome. The patient also had a medical history of pulmonary sarcoidosis with a restrictive ventilatory syndrome and obesity, which would be a supplementary risk to develop a poor outcomes. This case highlights the possible coinfection of two severe SARS-CoV-2 and influenza H1N1 viruses in comorbid patient, which presents a higher risk to extend the care duration. The overlapping clinical features of the two respiratory syndromes is a challenge, and awareness is required to recommend an early differential diagnosis and it’s necessary to adopt the vigilant preventive measures and therapeutic strategies to prevent a deleterious impacts in patients with comorbid factors.

Keywords